Seeking better outcomes for people with liver cancer

Click here to register to attend this event

WHEN: March 21, 6pm-7.15pm  

WHERE: University of Tasmania Medical Science Precinct, 17 Liverpool St, Hobart

Around 2,000 new cases of liver cancer will be diagnosed in Australia this year and, compared to other cancers, five-year survival rates are low. However the chances of successful treatment are improved if the cancer is detected early.

Six-monthly health checks are recommended for people at high risk of liver cancer, but this rarely occurs. As a result, many patients are diagnosed late in the progression, limiting treatment options and survival rates.

Menzies health economist Dr Barbara de Graaff and a research team are working with patient groups, clinicians, researchers and tech developers with the aim of developing a targeted screening program for liver cancer.

In this public talk Dr de Graaff will talk about her objectives in this research. Dr Cristina Moldovan, an oncologist at the Royal Hobart Hospital, will talk about the current treatments and prognosis for liver cancer patients, and Mr Alan Bottomley, whose family is helping to fund Dr De Graaff’s research, will speak about his experience of this disease and why it is important to support more research in this area.

SPEAKERS: Dr Barbara de Graaff, Menzies Institute for Medical Research, will speak about her research into screening for liver cancer

Dr Cristina Moldovan, Medical Oncologist, Royal Hobart Hospital, will speak about treatment and prognosis for liver cancer patients

Mr Alan Bottomley will speak from a personal perspective about his father, who died from liver cancer, and about his family's support for Dr de Graaff's research

Tea and coffee will be available from 5.30pm. The event will begin at 6pm.